Rethinking therapeutic and recreational nicotine products: a commentary on Hatsukami et al

被引：1

|

作者：

Borland, Ron ^{[1
]}

Gartner, Coral ^{[2
]}

机构：

[1] Canc Council Victoria, Melbourne, Vic 3004, Australia

[2] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia

来源：

TOBACCO CONTROL | 2016年 / 25卷 / 03期

关键词：

D O I：

10.1136/tobaccocontrol-2015-052388

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

引用

收藏

页码：245 / 245

页数：1

相关论文

共 50 条

[41] Commentary on Bamat et al.
Saad, Everardo D.
Buyse, Marc
CLINICAL TRIALS, 2020, 17 (05) : 560 - 561
[42] Commentary on the viewpoint of Nyman et al
Spinosa, DJ
Kaufmann, JA
Hartwell, GD
RADIOLOGY, 2002, 223 (02) : 328 - 329
[43] Commentary on Gardenbroek et al.
Bloom, Stuart
COLORECTAL DISEASE, 2012, 14 (05) : 553 - 554
[44] Commentary on Vrabelova et al.
Schmidt, HHJ
MOLECULAR GENETICS AND METABOLISM, 2005, 86 (1-2) : 11 - 12
[45] Commentary on Ravi et al.
Setchell, Jenny
Ross, Megan H.
PHYSIOTHERAPY CANADA, 2024, 76 (02) : 197 - 198
[46] It's not the electronic cigarette, it's the nicotine causing hemodynamic problems: A commentary on the article by Franzen et al.
Kastaun, Sabrina
Kotz, Daniel
VASCULAR MEDICINE, 2018, 23 (06) : 555 - 556
[47] Rethinking Access to Evidence-Based Treatments for Eating Disorders: A Commentary on Ali et al. 2024
Raykos, Bronwyn C.
INTERNATIONAL JOURNAL OF EATING DISORDERS, 2025, 58 (03) : 510 - 513
[48] Authors' response to the commentary by Kivela et al on Hany et al (2024)
Mighell, Alan J.
Inglehearn, Chris
JOURNAL OF MEDICAL GENETICS, 2024,
[49] RESPONSE TO GREENE ET AL.: INDUSTRY FUNDING AND PLACEBO QUIT RATE IN CLINICAL TRIALS OF NICOTINE REPLACEMENT THERAPY: A COMMENTARY ON ETTER ET AL. (2007)
Etter, Jean-Francois
Stapleton, John
ADDICTION, 2010, 105 (12) : 2219 - 2219
[50] COMMENTARY Cracking the almond (Commentary on Prevost et al.)
LaBar, Kevin S.
EUROPEAN JOURNAL OF NEUROSCIENCE, 2011, 34 (01) : 133 - 133

← 1 2 3 4 5 →